✨ Environmental and Health Notices
28 MARCH 2013 NEW ZEALAND GAZETTE, No. 38 1139
Departmental Notices
Environment
Resource Management Act 1991
The Resource Management (Approval of Hawke’s Bay Regional Investment Company Limited as Requiring Authority) Notice 2013
Pursuant to section 167 of the Resource Management Act 1991, the Minister for the Environment hereby gives the following notice.
Notice
-
Title—This notice may be cited as the Resource Management (Approval of Hawke’s Bay Regional Investment Company Limited as Requiring Authority) Notice 2013.
-
Approval as requiring authority for the distribution of water for supply—Hawke’s Bay Regional Investment Company Limited is approved as a requiring authority under section 167 of the Resource Management Act 1991, for the purpose of distribution of water for supply (including irrigation) associated with the Ruataniwha Water Storage Scheme located within the Central Hawke’s Bay District and Hastings District, including intake infrastructure for water taking and discharge to enable distribution of that water.
Dated at Wellington this 20th day of March 2013.
HON AMY ADAMS, Minister for the Environment.
go1888
Health
Medicines Act 1981
Consent to the Distribution of a New Medicine
Pursuant to section 20 of the Medicines Act 1981, the Minister of Health hereby consents to the distribution in New Zealand of the new medicine which was referred to the Minister of Health under the provisions of section 24(5) of the Act and is set out in the Schedule hereto:
Schedule
Product: Myozyme
Active Ingredient: Alglucosidase alfa 52.5mg
Dosage Form: Powder for infusion concentrate
New Zealand Sponsor: sanofi-aventis new zealand limited
Manufacturers: Genzyme Ireland Limited, Waterford, Ireland
Hospira Inc, Kansas, United States of America
Dated this 21st day of March 2013.
DR DON MACKIE, Chief Medical Officer, Clinical Leadership, Protection and Regulation Business Unit, Ministry of Health (pursuant to delegation given by the Minister of Health on 6 July 2001).
go1816
Consent to the Distribution of New Medicines
Pursuant to section 20 of the Medicines Act 1981, the Minister of Health hereby consents to the distribution in New Zealand of the new medicines set out in the Schedule hereto:
Schedule
Product: Concentrated Haemodialysis Solution Formula NGF - Part A (Article No. 2895)
Active Ingredients: Acetic acid 8.4g/L
Calcium chloride dihydrate 6.5g/L
Glucose 34.7g/L
Magnesium chloride hexahydrate 3.6g/L
Sodium chloride 214.8g/L
Dosage Form: Dialysis solution
New Zealand Sponsor: Fresenius Medical Care Australia Pty Limited (NZ)
Manufacturer: Fresenius Medical Care Australia Pty Limited, Smithfield, Australia
Next Page →
✨ LLM interpretation of page content
Approval of Hawke’s Bay Regional Investment Company Limited as Requiring Authority
Environment20 March 2013
Resource Management, Water Distribution, Hawke’s Bay, Ruataniwha Water Storage Scheme
- HON AMY ADAMS, Minister for the Environment
🏥 Consent to the Distribution of a New Medicine: Myozyme
🏥 Health & Social Welfare21 March 2013
Medicines Act, New Medicine, Myozyme, Alglucosidase alfa
- DR DON MACKIE, Chief Medical Officer, Clinical Leadership, Protection and Regulation Business Unit, Ministry of Health
🏥 Consent to the Distribution of New Medicines: Concentrated Haemodialysis Solution Formula NGF - Part A
🏥 Health & Social Welfare21 March 2013
Medicines Act, New Medicine, Haemodialysis Solution, Fresenius Medical Care
- DR DON MACKIE, Chief Medical Officer, Clinical Leadership, Protection and Regulation Business Unit, Ministry of Health
NZ Gazette 2013, No 38